Efficacy and Safety of Plasma Exchange with 5% Albumin to Modify Cerebrospinal Fluid and Plasma Amyloid-β Concentrations and Cognition Outcomes in Alzheimer’s Disease Patients: A Multicenter, Randomized, Controlled Clinical Trial
2017 ◽
Vol 56
(1)
◽
pp. 129-143
◽
2020 ◽
Vol 6
(1)
◽
2017 ◽
Vol 37
(11)
◽
pp. 1083-1091
◽
2011 ◽
Vol 84
(2)
◽
pp. 255-260
◽
2017 ◽
Vol 45
(4)
◽
pp. 418-425
◽
2018 ◽
Vol 49
◽
pp. 84-90
◽